Recent Comments

Comment RSS

Humana reports Q1 revenue increase driven by Medicare Advantage plan performance

29. April 2008 19:18

Humana on Monday announced that first-quarter revenue increased by 12% to $6.96 billion from $6.20 billion in the period last year, driven by higher-than-average enrollment in the company's Medicare Advantage plans, the Wall Street Journal reports.

The company also reported that first-quarter net income increased by 13% to $80.2 million, or 47 cents per share, from $71.2 million, or 42 cents per share, a year earlier (Kardos, Wall Street Journal, 4/28).

Analysts surveyed by Thomson Financial estimated higher first-quarter earnings of 45 cents per share on revenue of $6.94 billion (Schreiner, AP/San Francisco Chronicle, 4/28). The company in March estimated first-quarter earnings of between 44 cents and 46 cents per share as a result of higher-than-expected Medicare drug claims, but a lower effective tax rate helped overall profits (Wall Street Journal, 4/28). According to the AP/Chronicle, Humana's government segment, which includes Medicare and military health services, experienced a pretax loss of $3.2 million in the first-quarter, primarily because of $100 million in incremental expenses related to higher-than-expected claims in stand-alone Medicare drug plans. Those losses were offset by improved performance in MA plans and military services (AP/San Francisco Chronicle, 4/28).

The company also reported that its first-quarter medical-loss ratio declined to 86.7% from 86.8%, while the ratio in government plans increased by 0.7 percentage points to 90%, and its commercial segment experienced a 2.6-point drop to 76.8% because of two fourth-quarter acquisitions, the Journal reports. Overall plan membership increased by 0.7% to 11.4 million, and membership in dental and vision plans grew by more than three times to 6.9 million, from 1.9 million. Membership in MA plans increased by 14%, but membership in stand-alone drugs plans declined by 9.3% (Wall Street Journal, 4/22).

Humana officials increased full-year earnings projections to between $4.10 and $4.35 per share with revenue between $28 billion and $30 billion (AP/San Francisco Chronicle, 4/28).


Kaisernetwork.orgThis article is republished with kind permission from our friends at the The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Posted in: Pharmaceutical News

Tags: ,

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment



(Will show your Gravatar icon)
  Country flag

biuquote
  • Comment
  • Preview
Loading



News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.